Finance
The proceeds will be used to fund the clinical development of MyopiaX, the company's lead product in childhood myopia.
The Israeli company now has a total of $9 million in venture funding.
This brings the company's total raise to $140 million.
The company is planning on using the new funds to expand its library and build more capabilities.
The Boston and Tel Aviv-based company includes a predictive analytics tool which helps intervene in a person's aging trajectory.
Together the businesses have 900,000 subscribers.
The app aims to give users customised insights to help gain a holistic understanding of what impacts their overall health, mood and fitness.
This new funding brings the company's total funding pot to $135 million.
The new acquistiion is expected to help the company grow out its diagnostic capabilities.
The company's IPO included around 4.4 million shares.